BackOrion Biotech Opportunities - Warrants (15/04/2025) Overview
Orion Biotech Opportunities Corp - Warrants (15/04/2025)

Orion Biotech Opportunities - Warrants (15/04/2025) P/E Ratio

Orion Biotech Opportunities - Warrants (15/04/2025) (ORIAW) has a P/E ratio of 11.12, below the sector sector average of 34.56.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

11.12

P/E Ratio

11.12

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Orion Biotech Opportunities - Warrants (15/04/2025) (ORIAW) FAQ

Orion Biotech Opportunities - Warrants (15/04/2025)'s p/e ratio stands at 11.12. That is below the sector sector average of 34.56. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Orion Biotech Opportunities - Warrants (15/04/2025) sits lower the its sector benchmark (34.56) with a P/E ratio of 11.12. That is roughly 67.8% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 11.12 is attractive depends on Orion Biotech Opportunities - Warrants (15/04/2025)'s earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how Orion Biotech Opportunities - Warrants (15/04/2025)'s P/E ratio evolved across reporting periods, while the comparison chart places ORIAW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.